The Paradigm Shift in Metabolic Weight Loss: Integrating Regenerative Medicine to Mitigate Post-GLP-1 Tissue Flaccidity and Volume Loss
Written By: Steve Fong | Medically Reviewed by: One Day MD Editorial Team TL;DR: Losing weight fast on Ozempic is great, but it often leaves behind "Ozempic Body" (sagging skin and a hollow face). Doctors are now using stem cells, exosomes, and nanofat to rebuild the body from the inside out. Here is the science behind why weight loss needs a regenerative upgrade. Abstract The rapid global adoption of glucagon-like peptide-1 (GLP-1) receptor agonists—such as semaglutide and tirzepatide—has revolutionized obesity management. However, accelerated adipose tissue depletion frequently induces secondary aesthetic and structural sequelae, colloquially termed "Ozempic Body." This condition is characterized by dermal laxity, rhytids, facial lipoatrophy, and compromised extracellular matrix (ECM) integrity. This paper evaluates the synergistic integration of regenerative medicine modalities—specifically mesenchymal stem cell (MSC) therapy, nanofat grafti...